Claritev Corporation

NYSE:CTEV

Medical - Healthcare Information Services

Healthcare
$22.30 +1.41%

+$0.42 today

Market cap
$380.77M
Beta
0.77
P/E (TTM)
-1.8
EPS (TTM)
-$17.16
52W Low $11.50High $74.07

Volume 0.31M

Average 0.14M

CTEV Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Claritev CorporationNYSE: CTEV

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin narrows to 26.4%

Gross margin was 26.4% in Q1 FY2026, down 47.5 pp from a year earlier. On a trailing-twelve-month basis it was 61.1%, down 13.1 pp year over year. Over 3 fiscal years it narrowed by 53.5 pp.

Context

  • Gross margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
26.4%-42.0 pp QoQ
Last fiscal yearDec 2025
27.6%-46.7 pp YoY
LTMMar 2026
61.1%-13.1 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-47.5 pp——
1 year-46.7 pp——
3 years-53.5 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
27.6%
Year-over-year change
-46.7pp

Gross Margin vs competitors

How CTEV compares with its peers on the latest reported figures

  • CTEV's LTM Mar 2026 gross margin of 61.1% is the 7th highest of the 10 companies compared; the peer median is 76.8%.
  • Its year-over-year change of -13.1 pp is the lowest of 10, against a peer median of -2.1 pp.
  • Over three fiscal years its change of -53.5 pp compares with a peer median of -4.6 pp.
CTEV Competitors Peer median
Gross Margin for CTEV and competitors
Company Period LTM level YoY 3-year change
DNTHDianthus Therapeutics, Inc.LTM Jun 202696.0% -4.0 pp+0.0 pp
GDRXGoodRx Holdings, Inc.LTM Mar 202686.6% -7.3 pp+1.3 pp
LFMDLifeMD, Inc.LTM Mar 202685.9% -2.1 pp-4.6 pp
INMDInMode Ltd.LTM Mar 202677.8% -2.2 pp-5.3 pp
IRMDIRadimed CorporationLTM Mar 202676.8% -0.1 pp-0.7 pp
AXGNAxoGen, Inc.LTM Sep 202674.2% -0.6 pp-4.2 pp
CTEVClaritev CorporationLTM Mar 202661.1% -13.1 pp-53.5 pp
IARTIntegra LifeSciences Holdings CorporationLTM Mar 202653.2% -0.3 pp-10.6 pp
OPKOPKO Health, Inc.LTM Mar 202622.7% -6.2 pp-7.6 pp
EVHEvolent Health, Inc.LTM Mar 202614.1% -1.1 pp-8.3 pp
SANASana Biotechnology, Inc.FY2025— ——
Peer median (excluding CTEV) 76.8%-2.1 pp-4.6 pp

Competitors are the stored peer set for CTEV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.12B1.08B961.52M930.62M965.41M
Cost of Revenue175.29M204.1M235.47M239.4M698.84M
Gross Profit942.31M875.62M726.06M691.22M266.58M
Gross Margin84.3%81.1%75.5%74.3%27.6%
Research & Development00000
Selling, General & Admin151.1M132.14M135.99M160.22M221.52M
Operating Expenses556.19M1.24B564.07M2.08B221.52M
Depreciation & Amortization412.06M415.66M425.79M436.44M448.45M
EBITDA814.99M158.32M651.93M(1.01B)475.44M
EBITDA Margin72.9%14.7%67.8%-108.3%49.2%
Operating Income386.12M(362.73M)161.98M(1.39B)45.06M
Operating Margin34.5%-33.6%16.8%-149.4%4.7%
Interest Income30K3.5M8.23M3.13M1.56M
Interest Expense267.48M303.4M333.21M326.37M400.07M
Other Income / Expenses(250.67M)(198.01M)(269.04M)(380.78M)(418.14M)
Income Before Tax135.45M(560.74M)(107.06M)(1.77B)(373.08M)
Pre-Tax Margin12.1%-51.9%-11.1%-190.3%-38.6%
Income Tax Expense33.37M12.17M(15.36M)(124.88M)(88.8M)
Net Income102.08M(572.91M)(91.7M)(1.65B)(284.28M)
Net Margin9.1%-53.1%-9.5%-176.9%-29.4%
EPS (Basic)6.40(35.87)(5.69)(101.92)(17.30)
EPS (Diluted)6.40(35.87)(5.69)(101.92)(17.30)
Weighted Avg Shares16.28M15.97M16.13M16.15M16.43M
Weighted Avg Shares (Diluted)16.29M15.97M16.13M16.15M16.43M

Claritev Corporation

NYSE:CTEV

Intrinsic Alpha fair value

Locked

Current Price

$22.30

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.